Wellington Management Group
NEOS

Wellington Management Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Wellington Management Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,530
Closed -$178K – 2378
2017
Q4 		$178K Buy
+17,530
New +$168K ﹤0.01% 2184

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's NEOS Position: Q1 2018 in Review

Wellington Management Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2018, closing a stake of 17,530 shares — an estimated $178K sold.

Wellington Management Group first reported a position in NEOS in Q4 2017 and held it in 1 quarter. The position peaked at $178K in Q4 2017. 77 funds tracked by Wall St. Rank hold NEOS as of Q1 2018.

  • Wellington Management Group reported no remaining Neos Therapeutics, Inc position as of Q1 2018 after selling out during the quarter.
  • Wellington Management Group sold 17,530 Neos Therapeutics, Inc shares in Q1 2018, an estimated $178K.
  • Wellington Management Group first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 1 quarter.
  • Wellington Management Group's Neos Therapeutics, Inc position peaked at $178K in Q4 2017.
  • 77 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2018.

Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.